BioCardia Debt-to-Equity Ratio Growth & History (BCDA)

BioCardia's debt-to-equity ratio was 0.59 for fiscal 2025.

View full BioCardia company overview

BioCardia annual debt-to-equity ratio history

BioCardia annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.59−0.55−48.08%
20242024-12-311.14
20222022-12-310.330.15+85.17%
20212021-12-310.180.15+462.31%
20202020-12-310.03−0.45−93.36%
20192019-12-310.48

BioCardia debt-to-equity ratio trends

Over the last five fiscal years, BioCardia's debt-to-equity ratio increased from 0.03 to 0.59, a change of 0.56. The latest reported quarter, Q2 2026, shows 0.11.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioCardia source filings ↗

Community posts

It’s quiet here.

No posts about BCDA yet. Start the conversation.

Write the first post